Literature DB >> 31197511

Psychiatric disorders in multiple sclerosis.

Maddalena Sparaco1, Luigi Lavorgna1, Simona Bonavita2,3,4.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is characterized by a large spectrum of symptoms, involving all functional systems. Psychiatric symptoms are common in people with MS (pwMS) having an important impact on quality of life and on some features of MS (fatigue, sleep, disability, adherence to disease-modifying drugs). The main psychiatric disturbances in MS are depressive, bipolar, anxiety, schizophrenic and obsessive-compulsive syndromes.
METHODS: Literature search for original articles and review in the databases, including PubMed and Scopus from 1959 to 2019. RESULTS AND
CONCLUSION: Studies answering the aim of this review were selected and reported. Epidemiological and clinical aspects of psychiatric syndromes (PS) in MS as well as self-report diagnostic scales and radiological correlates of PS in MS are described. Moreover, some radiological studies about primary psychiatric disorders (PD) are reported to underline how gray matter atrophy, white matter abnormalities and corpus callosum involvement in these diseases, as features in common with MS, may explain the more frequent occurrence of PD in MS than in the general population.

Entities:  

Keywords:  Magnetic resonance imaging; Multiple sclerosis; Psychiatric disorders; Quality of life; Self-report scale

Mesh:

Year:  2019        PMID: 31197511     DOI: 10.1007/s00415-019-09426-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  131 in total

1.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

2.  Psychopathological changes and cognitive impairment in encephalomyelitis disseminata.

Authors:  R J Boerner; H P Kapfhammer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

3.  Interferon beta-1 a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial.

Authors:  S B Patten; L M Metz
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

4.  Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.

Authors:  G Tsivgoulis; N Triantafyllou; C Papageorgiou; M E Evangelopoulos; E Kararizou; C Sfagos; D Vassilopoulos
Journal:  Acta Neurol Scand       Date:  2007-01       Impact factor: 3.209

5.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

6.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

7.  Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review.

Authors:  Majid Gasim; Charles N Bernstein; Lesley A Graff; Scott B Patten; Renee El-Gabalawy; Jitender Sareen; James M Bolton; James J Marriott; John D Fisk; R A Marrie
Journal:  Mult Scler Relat Disord       Date:  2018-09-12       Impact factor: 4.339

8.  Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.

Authors:  Sven Schippling; Paul O'Connor; Volker Knappertz; Christoph Pohl; Timon Bogumil; Gustavo Suarez; Stuart Cook; Massimo Filippi; Hans-Peter Hartung; Giancarlo Comi; Douglas R Jeffery; Ludwig Kappos; Douglas S Goodin; Barry Arnason
Journal:  J Neurol       Date:  2016-05-13       Impact factor: 4.849

9.  Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.

Authors:  Ruth Ann Marrie; Randy Walld; James M Bolton; Jitender Sareen; John R Walker; Scott B Patten; Alexander Singer; Lisa M Lix; Carol A Hitchon; Renée El-Gabalawy; Alan Katz; John D Fisk; Charles N Bernstein
Journal:  BMC Res Notes       Date:  2017-11-25

10.  Telephone-administered psychotherapy for depression in MS patients: moderating role of social support.

Authors:  Victoria Beckner; Isa Howard; Lea Vella; David C Mohr
Journal:  J Behav Med       Date:  2009-11-26
View more
  7 in total

1.  Predictors of Mood Disorders in Parents With Multiple Sclerosis: The Role of Disability Level, Coping Techniques, and Perceived Social Support.

Authors:  Jessica Podda; Michele Messmer Uccelli; Andrea Tacchino; Ludovico Pedullà; Margherita Monti Bragadin; Mario Alberto Battaglia; Giampaolo Brichetto; Michela Ponzio
Journal:  Int J MS Care       Date:  2022-06-20

Review 2.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

3.  Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic.

Authors:  Maddalena Sparaco; Giuseppina Miele; Luigi Lavorgna; Gianmarco Abbadessa; Simona Bonavita
Journal:  Neurol Sci       Date:  2022-01-29       Impact factor: 3.830

4.  Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.

Authors:  Huan Tu; Ning Li; Wanna Liu; Zhonghe Fan; Dezhi Kong
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

Review 5.  Depression in multiple system atrophy: Views on pathological, clinical and imaging aspects.

Authors:  Qiuyi Lv; Yuxin Pan; Xing Chen; Jingpei Wei; Wei Wang; Hua Zhang; Jifeng Wan; Shiqiang Li; Yan Zhuang; Baolin Yang; Dayong Ma; Dawei Ren; Zijun Zhao
Journal:  Front Psychiatry       Date:  2022-09-08       Impact factor: 5.435

6.  Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy.

Authors:  Karine Eid; Øivind Torkildsen; Jan Aarseth; Elisabeth G Celius; Marianna Cortese; Trygve Holmøy; Akash Kapali; Kjell-Morten Myhr; Cecilie F Torkildsen; Stig Wergeland; Nils Erik Gilhus; Marte-Helene Bjørk
Journal:  J Neurol       Date:  2022-07-03       Impact factor: 6.682

7.  Vitamin D Supplementation and Mental Health in Multiple Sclerosis Patients: A Systematic Review.

Authors:  Dominika Głąbska; Aleksandra Kołota; Katarzyna Lachowicz; Dominika Skolmowska; Małgorzata Stachoń; Dominika Guzek
Journal:  Nutrients       Date:  2021-11-24       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.